Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
7hon MSN
Prostate cancer breakthrough: life-extending drug will be offered to thousands of men within weeks
For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...
News-Medical.Net on MSN
Cancer mortality drops 34% as treatments and early detection improve
The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...
While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback